Friday, July 11, 2025
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Fiinews
No Result
View All Result
Home Exports

GVK BIO appoints Dr Schleyer as CEO of Aragen

Fiinews by Fiinews
May 9, 2019
in Exports, Health, Technology
Reading Time: 2 mins read
A A
0
0
SHARES
14
VIEWS
LinkedinShare on Twitter

0:00

Biologics research grows rapidly

 

GVK Bio.
GVK Bio executives.

Hyderabad-headquartered GVK BIO has appointed Dr. Axel Schleyer as Chief Executive Officer, Aragen Bioscience Inc, a wholly-owned subsidiary in San Francisco.

“I am delighted to welcome Dr. Axel Schleyer as the Chief Executive Officer, Aragen Bioscience. Axel brings a wealth of business, technology, regulatory and strategic acumen, and has an impressive record of consistently delivering high performance with a customer focus,” said Manni Kantipudi, Chairman, Aragen Bioscience, Director & CEO, GVK BIO.

“We are confident that under his leadership, Aragen will expand its offering, and build on its growth over the past few years,” he said.

“I am excited to lead Aragen Bioscience and look forward to assisting our customers in developing solutions that impact human health. With large molecules contributing to approximately 40% of the global portfolio, interest in Biologics research continues to grow rapidly,” added Dr. Axel Schleyer.

“With its strong scientific leadership, ‘customer first’ culture, state-of-the-art infrastructure, and an ideal location in the Bay area, Aragen is well positioned to benefit from market trends,” Dr Schleyer underlined.

A seasoned Pharmaceutical and Biotechnology professional, Dr. Schleyer has over two decades of industry experience, building and leading high-performance teams, spearheading global business initiatives, and formulating business strategies resulting in successful outcomes.

Prior to joining Aragen, Dr. Schleyer served as Senior Vice President, AGC Biologics and has held roles of increasing responsibilities at Lonza, Siegfried, Baxter Healthcare and Boehringer Ingelheim.

GVK BIO, a leading Contract Research & Development Organization servicing the global Biopharma industry, is headquartered in Hyderabad, with operations in five sites including California in the United States.

Aragen Bioscience, a wholly owned subsidiary of GVK BIO, is a leading contract research organization based in the San Francisco Bay Area. Aragen Bioscience offers a diverse set of In Vitro and In Vivo services for the discovery, characterization, activity assessment and early development of biologic and diagnostic products. fiinews.com

ShareTweetShare

Related Posts

Ansrsource With Tagline
Technology

Tech: ansrsource-ANSR reshape talent across India

by Fiinews
July 11, 2025
0
18

Ahuja to help clients achieve unprecedented levels of operational excellence Austin’s ansrsource has formed a strategic partnership with ANSR, the...

Infogain
Infogain

Tech: Infogain launches GCC solutions in India

by Fiinews
July 11, 2025
0
18

GCC solutions for AI-driven talent, infrastructure and processes Infogain, a leader in digital customer experience engineering based in Silicon Valley,...

Agriculture Of Bihar

Export: Rs20lcr potential for agriculture supplies

July 11, 2025
20
PIB

Export: India-SACU PTA talks to be expedited

July 11, 2025
19
Synergy Quantum

Tech: Partners work on India’s first space infra

July 10, 2025
13
PIB

Export: India-Brazil set $20bn trade target

July 10, 2025
24
SBI YONO

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0
  • Technologies: Royal Diamond sponsors aerspace Industries’ drones in UAE

    0 shares
    Share 0 Tweet 0
  • Investments: Foreign investors see India as long-term destination for fund placings

    0 shares
    Share 0 Tweet 0
  • Markets: Blue Dart maintains positive outlook on India

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Project: Mindset change is critical for innovation
  • Project: 4,000% in installed solar capacity
  • Project: EV policies part of climate goals
  • Tech: ansrsource-ANSR reshape talent across India
  • Tech: Infogain launches GCC solutions in India

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports

© 2024 FIINEWS - Design and developed by 7clicksmedia.